Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 0.00 | € 522.18M | € 702.58M | € 717.21M | € 474.59M |
Total Assets | - | € 1.67B | € 1.80B | € 1.95B | € 1.89B |
Total Debt | € 0.00 | € 132.11M | € 251.80M | € 338.63M | € 338.76M |
Net Debt | € 0.00 | € -390.07M | € -450.77M | € -378.58M | € -135.84M |
Total Liabilities | - | € 191.38M | € 345.61M | € 466.89M | € 517.35M |
Stockholders Equity | € 0.00 | € 1.48B | € 1.45B | € 1.48B | € 1.37B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |